- Home
- CLNN vs CLPS Comparison
CLNN vs CLPS Comparison
Compare CLNN & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- CLPS
- Stock Information
- Founded
- CLNN 2012
- CLPS 2005
- Country
- CLNN United States
- CLPS Hong Kong
- Employees
- CLNN N/A
- CLPS N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- CLNN Health Care
- CLPS Technology
- Exchange
- CLNN Nasdaq
- CLPS Nasdaq
- Market Cap
- CLNN 23.1M
- CLPS 27.2M
- IPO Year
- CLNN N/A
- CLPS 2018
- Fundamental
- Price
- CLNN $5.95
- CLPS $1.04
- Analyst Decision
- CLNN Strong Buy
- CLPS
- Analyst Count
- CLNN 5
- CLPS 0
- Target Price
- CLNN $33.00
- CLPS N/A
- AVG Volume (30 Days)
- CLNN 101.0K
- CLPS 7.8K
- Earning Date
- CLNN 08-14-2025
- CLPS 10-17-2025
- Dividend Yield
- CLNN N/A
- CLPS 12.18%
- EPS Growth
- CLNN N/A
- CLPS N/A
- EPS
- CLNN N/A
- CLPS N/A
- Revenue
- CLNN $286,000.00
- CLPS $153,816,045.00
- Revenue This Year
- CLNN N/A
- CLPS N/A
- Revenue Next Year
- CLNN $2,178.18
- CLPS N/A
- P/E Ratio
- CLNN N/A
- CLPS N/A
- Revenue Growth
- CLNN N/A
- CLPS 5.81
- 52 Week Low
- CLNN $2.28
- CLPS $0.80
- 52 Week High
- CLNN $6.90
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- CLNN 65.46
- CLPS 59.53
- Support Level
- CLNN $5.12
- CLPS $0.96
- Resistance Level
- CLNN $6.49
- CLPS $1.07
- Average True Range (ATR)
- CLNN 0.63
- CLPS 0.03
- MACD
- CLNN 0.10
- CLPS 0.01
- Stochastic Oscillator
- CLNN 81.76
- CLPS 81.25
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.